{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05163301",
            "orgStudyIdInfo": {
                "id": "IRB00288483"
            },
            "organization": {
                "fullName": "Johns Hopkins University",
                "class": "OTHER"
            },
            "briefTitle": "Alcohol Research in HIV: Relapse Prevention",
            "officialTitle": "Alcohol Research Consortium in HIV: Relapse Prevention Arm",
            "acronym": "ARCH-RPA",
            "therapeuticArea": [
                "Infectious Diseases",
                "Other"
            ],
            "study": "alcohol-research-in-hiv-relapse-prevention"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-03-27",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-02-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-05-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-12-06",
            "studyFirstSubmitQcDate": "2021-12-06",
            "studyFirstPostDateStruct": {
                "date": "2021-12-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-29",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-30",
                "type": "ESTIMATED"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Johns Hopkins University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute on Alcohol Abuse and Alcoholism (NIAAA)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "3-arm type 1 pilot implementation-efficacy trial for people with alcohol use disorders to examine the preliminary effectiveness and feasibility of an adapted 2-session, computerized and person delivered relapse prevention intervention.",
            "detailedDescription": "This study will develop a brief counseling intervention for people with HIV who have resumed alcohol use or resumed hazardous alcohol use after a minimum of 3 years of alcohol abstinence or 'lower risk' alcohol use. The investigators will develop a 2session person delivered and a 2-session computer delivered intervention which the investigators will then compare with the usual treatment for alcohol counseling offered at the HIV clinic. The investigators will also study the acceptability and feasibility of implementing both types of counseling in the clinic."
        },
        "conditionsModule": {
            "conditions": [
                "HIV",
                "Alcohol Use Disorder"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "one group will receive computer delivered relapse prevention intervention (RPI); one group will receive person delivered relapse prevention intervention; one group will receive usual care",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 150,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Computer delivered RPI",
                    "type": "EXPERIMENTAL",
                    "description": "2 session computer delivered counseling to prevent relapse to hazardous drinking",
                    "interventionNames": [
                        "Behavioral: Relapse Prevention Intervention"
                    ]
                },
                {
                    "label": "Person delivered RPI",
                    "type": "EXPERIMENTAL",
                    "description": "2 session counselor delivered counseling to prevent relapse to hazardous drinking",
                    "interventionNames": [
                        "Behavioral: Relapse Prevention Intervention"
                    ]
                },
                {
                    "label": "Treatment as Usual",
                    "type": "NO_INTERVENTION",
                    "description": "Counseling for alcohol use available in clinic as treatment as usual"
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Relapse Prevention Intervention",
                    "description": "2 session intervention to address relapse prevention among people with HIV who have an alcohol use disorder",
                    "armGroupLabels": [
                        "Computer delivered RPI",
                        "Person delivered RPI"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in time to relapse",
                    "description": "Time to return to any alcohol use or any at risk alcohol use after intervention.",
                    "timeFrame": "6 and 12 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Alcohol use pattern as assessed by change in number of drinking days",
                    "description": "Number of drinking days.",
                    "timeFrame": "Baseline, 6 and 12 months"
                },
                {
                    "measure": "Alcohol use pattern as assessed by change in number of heavy drinking days",
                    "description": "Number of heavy drinking days.",
                    "timeFrame": "Baseline, 6 and 12 months"
                },
                {
                    "measure": "Alcohol use pattern as assessed by change in number of drinks per drinking day",
                    "description": "Number of drinks per drinking day.",
                    "timeFrame": "Baseline, 6 and 12 months"
                },
                {
                    "measure": "Alcohol use pattern as assessed by change in number of days abstinent",
                    "description": "Number of days abstinent.",
                    "timeFrame": "Baseline, 6 and 12 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Confirmed diagnosis of HIV\n* Aged 18 years or older\n* Must be enrolled in clinical care at Johns Hopkins HIV Clinic.\n\nIn addition, meet the following alcohol use criteria:\n\n1. lifetime alcohol use disorder\n2. patient reported outcomes (PRO) assessment collected by the Center for AIDS Research (CFAR) Network of Clinical Systems as part of usual clinical care that show in the last 3 years: periods of no or lower risk drinking (e.g. women/men who are drinking \\<11/22 drinks per week) and periods of lapse to higher levels of drinking (=\\>11/22 drinks per week for women/men)\n3. current PRO showing alcohol abstinence or alcohol use at \\<11/22 drinks per week for women/men.\n\nExclusion Criteria:\n\n* Acutely suicidal, homicidal, psychotic or otherwise unable to provide informed consent\n* Non-English speaking because interventions are currently available in English only",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Heidi Hutton, PhD",
                    "role": "CONTACT",
                    "phone": "14104586715",
                    "email": "hhutton@jhmi.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Heidi Hutton, PhD",
                    "affiliation": "Johns Hopkins School of Medicine",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Johns Hopkins School of Medicine",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21287",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Heidi Hutton",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Heidi Hutton, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "NIAAA has begun a new data-sharing initiative to create a data repository of future NIAAA-funded studies that include human subjects. This repository is called the NIAAA Data Archive (NIAAA DA). NIAAA-funded investigators conducting human subjects research are expected to submit de-identified, individual-level data to this data archive.\n\nThe NIAAA DA accepts only electronic, de-identified data from human subjects studies. Data submitted to the NIAAA DA must be de-identified by the investigator prior to submission.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP"
            ],
            "timeFrame": "Data will be shared with the general research community 2 years after the grant end date on the initial Notice of Award. This 2-year embargo period will provide study investigators with protected time to publish from the study data. After the embargo, the data will be made available for sharing with the general research community via the NIAAA DA website. However, if a manuscript using study data is accepted for publication prior to the 2-year embargo, the study data specifically used in that manuscript will be shared with the general research community at the time of publication.",
            "accessCriteria": "Investigators at institutions with a Federal Wide Assurance (FWA) will be able to gain access to NIAAA DA data by submitting a data access request in accordance with applicable NIAAA DA policies. Data requests will be reviewed and granted by a NIAAA Data Access Committee.",
            "url": "https://grants.nih.gov/grants/guide/notice-files/NOT-AA-19-020.html"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000437",
                    "term": "Alcoholism"
                }
            ],
            "ancestors": [
                {
                    "id": "D000019973",
                    "term": "Alcohol-Related Disorders"
                },
                {
                    "id": "D000019966",
                    "term": "Substance-Related Disorders"
                },
                {
                    "id": "D000064419",
                    "term": "Chemically-Induced Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3522",
                    "name": "Acquired Immunodeficiency Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M18250",
                    "name": "HIV Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M3774",
                    "name": "Alcohol Drinking",
                    "relevance": "LOW"
                },
                {
                    "id": "M3783",
                    "name": "Alcoholism",
                    "asFound": "Alcohol Use Disorder",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21842",
                    "name": "Alcohol-Related Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M21837",
                    "name": "Substance-Related Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M30302",
                    "name": "Chemically-Induced Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M3777",
                    "name": "Ethanol",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}